Ipca Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,563.70
19.75 (1.28%)
BSENSE

May 06

BSE+NSE Vol: 2.94 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Ipca Labs
Laurus Labs
Emcure Pharma
Gland Pharma
Ajanta Pharma
J B Chemicals &
Abbott India
Anthem Bioscienc
Biocon
Glaxosmi. Pharma
Wockhardt

Why is Ipca Laboratories Ltd ?

1
Company has a Debt to Equity ratio (avg) of 0.04 times
2
The company has declared Positive results for the last 7 consecutive quarters
  • ROCE(HY) Highest at 17.89%
  • INVENTORY TURNOVER RATIO(HY) Highest at 3.72 times
  • PAT(Q) At Rs 311.86 cr has Grown at 27.4% (vs previous 4Q average)
3
High Institutional Holdings at 48.08%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
  • Along with generating 13.32% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Ipca Labs should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Ipca Labs for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Ipca Labs
13.32%
0.44
30.47%
Sensex
-3.33%
-0.25
13.43%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.06%
EBIT Growth (5y)
3.67%
EBIT to Interest (avg)
49.00
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.98
Tax Ratio
26.88%
Dividend Payout Ratio
13.76%
Pledged Shares
0
Institutional Holding
48.08%
ROCE (avg)
18.54%
ROE (avg)
12.01%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
38
Industry P/E
34
Price to Book Value
5.37
EV to EBIT
26.39
EV to EBITDA
20.75
EV to Capital Employed
5.36
EV to Sales
4.20
PEG Ratio
0.91
Dividend Yield
0.13%
ROCE (Latest)
19.48%
ROE (Latest)
13.19%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
ROCE(HY)

Highest at 17.89%

INVENTORY TURNOVER RATIO(HY)

Highest at 3.72 times

PAT(Q)

At Rs 311.86 cr has Grown at 27.4% (vs previous 4Q average

EPS(Q)

Highest at Rs 12.86

-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 263.80 cr

Loading Valuation Snapshot...

Here's what is working for Ipca Labs

Inventory Turnover Ratio- Half Yearly
Highest at 3.72 times and Grown
each half year in the last five half yearly periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Profit After Tax (PAT) - Quarterly
At Rs 311.86 cr has Grown at 27.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 244.82 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 12.86
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Ipca Labs

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 263.80 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents